



SIMPULAN DAN SARAN 
 
6.1 Simpulan 
Pada penelitian ini pemberian fluphenazine decanoate bertingkat 
pada 15 ekor tikus wistar jantan berusia 3 bulan dengan berat badan 
kurang lebih 200 gram selama 28 hari memberikan hasil :  
1. Terdapat kerusakan hepar dan kenaikan kadar enzim katalase  tikus 
wistar terpapar fluphenazine decanoate. 
2. Kadar katalase tertinggi didapat pada kelompok perlakuan 2 mg dan 
kadar terendah terdapat pada kelompok tanpa perlakuan. 
3. Rerata skor histopatologi hepar tertinggi didapat pada kelompok 
perlakuan 2 mg dan rerata terendah pada kelompok tanpa perlakuan. 
4. Kerusakan histopatologi hepar terparah dengan rerata histopatologi 
2,5 dan kadar katalase tertinggi dengan persentase 62,5% 
didapatkan pada kelompok perlakuan 2 mg. 
Penggunaan obat fluphenazine decanoate dengan dosis 2 mg 









1. Mengetahui efek fluphenazine decanoate dengan membandingkan 
dua marker antioksidan enzimatik dengan rerata skor histopatologi 
hepar. 
2. Perlunya dilakukan penelitian lain mengenai efek fluphenazine 
decanoate terhadap kadar katalase dengan menggunakan cara 
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  Kelompok Cases 
    Valid Missing Total 
    N Percent N Percent N 
Perc
ent 
Skoring Histopatologi kelompok kontrol 
5 100,0% 0 ,0% 5 
100,0
% 
  kelompok P1 
5 100,0% 0 ,0% 5 
100,0
% 
  kelompok P2 






  Kelompok   Statistic Std. Error 
Skoring Histopatologi kelompok kontrol Mean 157,4000 3,34066 
95% Confidence 
Interval for Mean 
Lower Bound 148,1248   
Upper Bound 
166,6752   
5% Trimmed Mean 157,6667   
Median 158,0000   
Variance 55,800   
Std. Deviation 7,46994   
Minimum 146,00   
Maximum 164,00   
Range 18,00   
Interquartile Range 13,50   
Skewness -,920 ,913 
Kurtosis ,317 2,000 
kelompok P1 Mean 185,4000 3,72290 
95% Confidence 
Interval for Mean 
Lower Bound 175,0636   
Upper Bound 
195,7364   
5% Trimmed Mean 184,9444   
Median 183,0000   
Variance 69,300   
Std. Deviation 8,32466   
Minimum 179,00   
Maximum 200,00   
Range 21,00   
Interquartile Range 11,00   
Skewness 2,010 ,913 
Kurtosis 4,315 2,000 
66 
 
kelompok P2 Mean 250,0000 6,22896 
95% Confidence 
Interval for Mean 
Lower Bound 232,7056   
Upper Bound 
267,2944   
5% Trimmed Mean 250,0556   
Median 251,0000   
Variance 194,000   
Std. Deviation 13,92839   
Minimum 232,00   
Maximum 267,00   
Range 35,00   
Interquartile Range 26,50   
Skewness -,142 ,913 
Kurtosis -1,304 2,000 
 
 Tests of Normality 
 
  Kelompok Kolmogorov-Smirnov(a) Shapiro-Wilk 
    Statistic df Sig. Statistic df Sig. 
Skoring Histopatologi kelompok kontrol 
,212 5 ,200(*) ,895 5 
,38
4 
  kelompok P1 
,413 5 ,005 ,727 5 
,01
8 
  kelompok P2 
,141 5 ,200(*) ,982 5 
,94
6 
*  This is a lower bound of the true significance. 
a  Lilliefors Significance Correction 
 
 
 Case Processing Summary 
 
  kelompok 
Cases 
Valid Missing Total 
N Percent N Percent N Percent 
kadar kelompok kontrol 5 100,0% 0 ,0% 5 100,0% 
kelompok P1 5 100,0% 0 ,0% 5 100,0% 









  kelompok   Statistic Std. Error 
kadar kelompok kontrol Mean 2,5500 ,33912 
95% Confidence 
Interval for Mean 
Lower Bound 1,6085   
Upper Bound 
3,4915   
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5% Trimmed Mean 2,5556   
Median 2,5000   
Variance ,575   
Std. Deviation ,75829   
Minimum 1,50   
Maximum 3,50   
Range 2,00   
Interquartile Range 1,38   
Skewness -,226 ,913 
Kurtosis -,139 2,000 
kelompok P1 Mean 3,9500 ,49624 
95% Confidence 
Interval for Mean 
Lower Bound 2,5722   
Upper Bound 
5,3278   
5% Trimmed Mean 3,9444   
Median 3,5000   
Variance 1,231   
Std. Deviation 1,10962   
Minimum 2,75   
Maximum 5,25   
Range 2,50   
Interquartile Range 2,13   
Skewness ,364 ,913 
Kurtosis -2,701 2,000 
kelompok P2 Mean 10,3500 ,61543 
95% Confidence 
Interval for Mean 
Lower Bound 8,6413   
Upper Bound 
12,0587   
5% Trimmed Mean 10,2639   
Median 9,7500   
Variance 1,894   
Std. Deviation 1,37614   
Minimum 9,50   
Maximum 12,75   
Range 3,25   
Interquartile Range 2,00   
Skewness 1,979 ,913 
Kurtosis 3,973 2,000 
 
 Tests of Normality 
 
  kelompok 
Kolmogorov-Smirnov(a) Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
kadar kelompok kontrol ,146 5 ,200(*) ,992 5 ,985 
kelompok P1 ,257 5 ,200(*) ,882 5 ,318 
kelompok P2 ,329 5 ,082 ,724 5 ,017 
*  This is a lower bound of the true significance. 








  kelompok N Mean Rank Sum of Ranks 
histopatologi hepar kelompok kontrol 5 3,00 15,00 
kelompok P1 5 8,00 40,00 









Mann-Whitney U ,000 
Wilcoxon W 15,000 
Z -2,627 
Asymp. Sig. (2-tailed) ,009 
Exact Sig. [2*(1-tailed 
Sig.)] ,008(a) 
a  Not corrected for ties. 




  kelompok N Mean Rank Sum of Ranks 
histopatologi hepar kelompok kontrol 5 3,00 15,00 
kelompok P2 5 8,00 40,00 
Total 10     
 





Mann-Whitney U ,000 
Wilcoxon W 15,000 
Z -2,619 
Asymp. Sig. (2-tailed) ,009 
Exact Sig. [2*(1-tailed 
Sig.)] ,008(a) 
a  Not corrected for ties. 




  kelonpok N Mean Rank Sum of Ranks 
histopatologi kelompok P1 5 3,00 15,00 
kelompok P2 5 8,00 40,00 
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Total 10     
 
 Test Statistics(b) 
 
  histopatologi 
Mann-Whitney U ,000 
Wilcoxon W 15,000 
Z -2,619 
Asymp. Sig. (2-tailed) ,009 
Exact Sig. [2*(1-tailed 
Sig.)] ,008(a) 
a  Not corrected for ties. 




  kelompok N Mean Rank Sum of Ranks 
kadar katalase kelompok kontrol 5 3,70 18,50 
kelompok P1 5 7,30 36,50 
Total 10     
 





Mann-Whitney U 3,500 
Wilcoxon W 18,500 
Z -1,886 
Asymp. Sig. (2-tailed) ,059 
Exact Sig. [2*(1-tailed 
Sig.)] ,056(a) 
a  Not corrected for ties. 








  kelompok N Mean Rank Sum of Ranks 
kadar katalase kelompok kontrol 5 3,00 15,00 
kelompok P2 5 8,00 40,00 
Total 10     
 





Mann-Whitney U ,000 




Asymp. Sig. (2-tailed) ,009 
Exact Sig. [2*(1-tailed 
Sig.)] ,008(a) 
a  Not corrected for ties. 




  kelompok N Mean Rank Sum of Ranks 
kadar katalase kelompok P1 5 3,00 15,00 
kelompok P2 5 8,00 40,00 
Total 10     
 





Mann-Whitney U ,000 
Wilcoxon W 15,000 
Z -2,619 
Asymp. Sig. (2-tailed) ,009 
Exact Sig. [2*(1-tailed 
Sig.)] ,008(a) 
a  Not corrected for ties. 












    N Mean Rank Sum of Ranks 
katalase - histopatologi Negative Ranks 1(a) 1,00 1,00 
Positive Ranks 4(b) 3,50 14,00 
Ties 0(c)     
Total 5     
a  katalase < histopatologi 
b  katalase > histopatologi 
c  katalase = histopatologi 
 








Asymp. Sig. (2-tailed) ,080 
a  Based on negative ranks. 




    N Mean Rank Sum of Ranks 
katalase - histopatologi Negative Ranks 0(a) ,00 ,00 
Positive Ranks 5(b) 3,00 15,00 
Ties 0(c)     
Total 5     
a  katalase < histopatologi 
b  katalase > histopatologi 
c  katalase = histopatologi 
 






Asymp. Sig. (2-tailed) ,043 
a  Based on negative ranks. 




    N Mean Rank Sum of Ranks 
katalase - histopatologi Negative Ranks 0(a) ,00 ,00 
Positive Ranks 5(b) 3,00 15,00 
Ties 0(c)     
Total 5     
a  katalase < histopatologi 
b  katalase > histopatologi 
c  katalase = histopatologi 
 






Asymp. Sig. (2-tailed) ,043 
a  Based on negative ranks. 
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